Literature DB >> 8180376

A mutation of the common receptor subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor, and IL-5 that leads to ligand independence and tumorigenicity.

R D'Andrea1, J Rayner, P Moretti, A Lopez, G J Goodall, T J Gonda, M Vadas.   

Abstract

The cytokines interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor bind with high affinity to a receptor complex that contains a ligand-specific alpha-chain and a common beta-chain, h beta c. We report here the isolation of a mutant form of h beta c, from growth factor-independent cells, that arose spontaneously after infection of a murine factor-dependent hematopoietic cell line (FDC-P1) with a retroviral h beta c expression construct. Analysis of this h beta c mutation shows that a small (37 amino acid) duplication of extracellular sequence that includes two conserved sequence motifs is sufficient to confer ligand-independent growth on these cells and lead to tumourigenicity. Because this is a conserved region in the cytokine receptor superfamily, our results suggest that the large family of cytokine receptors has the capacity to become oncogenically active.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180376

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2.  CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.

Authors:  Ningning Zhu; Yueyang Yang; Haitong Wang; Peng Tang; Hongdian Zhang; Haiyan Sun; Lei Gong; Zhentao Yu
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

3.  Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.

Authors:  F C Stomski; Q Sun; C J Bagley; J Woodcock; G Goodall; R K Andrews; M C Berndt; A F Lopez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

4.  Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice.

Authors:  R J D'Andrea; D Harrison-Findik; C M Butcher; J Finnie; P Blumbergs; P Bartley; M McCormack; K Jones; R Rowland; T J Gonda; M A Vadas
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

5.  Sequential mutations in the interleukin-3 (IL3)/granulocyte-macrophage colony-stimulating factor/IL5 receptor beta-subunit genes are necessary for the complete conversion to growth autonomy mediated by a truncated beta C subunit.

Authors:  J Hannemann; T Hara; M Kawai; A Miyajima; W Ostertag; C Stocking
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

6.  Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling.

Authors:  B J Jenkins; R D'Andrea; T J Gonda
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

7.  Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia.

Authors:  K Watanabe-Smith; C Tognon; J W Tyner; J P P Meijerink; B J Druker; A Agarwal
Journal:  Leukemia       Date:  2016-04-27       Impact factor: 11.528

8.  Discovery of a novel potentially transforming somatic mutation in CSF2RB gene in breast cancer.

Authors:  Mamoon Rashid; Rizwan Ali; Bader Almuzzaini; Hao Song; Alshaimaa AlHallaj; Al Abdulrahman Abdulkarim; Omar Mohamed Baz; Hajar Al Zahrani; Muhammed Mustafa Sabeena; Wardah Alharbi; Mohamed Hussein; Mohamed Boudjelal
Journal:  Cancer Med       Date:  2021-11-02       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.